From evidence to impact: how Cochrane Thailand is turning research into practice
Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.
What makes Cochrane’s new AI study innovative?
Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.
Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.
Cochrane Methods Executive seeks new Methods Group Convenor representative
We seek nominations for one upcoming vacant position on the Cochrane Methods Executive, to start in September 2026. Please note the deadline for nominations is Friday, 29 May 2026.
Celebrating 10 years of Cochrane Russia: a decade of collaboration and impact
Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo
Simple antiseptic can reduce newborn infections
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.
Rupa Sarkar joins Cochrane as Editor in Chief
The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.
Cochrane launches webinar series on GRADE methodology
Cochrane is launching a new eight-part series of Cochrane Learning Live webinars designed to help systematic reviewers understand and apply the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) framework in evaluating the certainty of evidence in their systematic reviews.
Cochrane announces selected AI tools for innovative platform study
Cochrane has confirmed the two artificial intelligence (AI) tools selected to take part in our innovative platform study evaluating how artificial intelligence could support and enhance key stages of evidence synthesis.
News
News
Trusted evidence.
Informed decisions.
Better health.
Informed decisions.
Better health.
11-13 Cavendish Square
London
W1G 0AN
United Kingdom
The Cochrane Collaboration is a charity (no. 1045921) and a company limited by guarantee (no. 03044323) registered in England & Wales. VAT registration number GB 718 2127 49.
Copyright © 2026 The Cochrane Collaboration